Literature DB >> 11297916

Visceral leishmaniasis in a patient with acquired hypogammaglobulinemia.

D Voutsinas1, L Foudoulaki, K Sofroniadou, N Galanakis.   

Abstract

A case of visceral leishmaniasis in a 26-year-old man with acquired IgA and IgG2 hypogammaglobulinemia, secondary to carbamazepine therapy given because of a previous head injury, is presented. The patient's clinical picture was otherwise typical, although hypogammaglobulinemia resulted in a delay in diagnosis, and response to therapy was excellent. This case is noteworthy because it is the first reported case of visceral leishmaniasis in a hypogammaglobulinemic patient and also because it is the fifth case of hypogammaglobulinemia due to carbamazepine reported worldwide.

Entities:  

Year:  2001        PMID: 11297916     DOI: 10.1016/s0953-6205(01)00111-x

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.

Authors:  Zenichiro Kato; Mizuho Watanabe; Naomi Kondo
Journal:  Eur J Pediatr       Date:  2003-01-25       Impact factor: 3.183

2.  Recurrent herpes simplex virus encephalitis secondary to carbamazepine induced hypogammaglobulinaemia.

Authors:  Claire M Rice; Sarah L Johnston; David J Unsworth; Stuart C Glover; Matthew Donati; Shelley A Renowden; John Holloway; Sam D Lhatoo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

3.  Secondary bronchiolitis obliterans organising pneumonia in a patient with carbamazepine-induced hypogammaglobulinaemia.

Authors:  T Tamada; M Nara; M Tomaki; Y Ashino; T Hattori
Journal:  BMJ Case Rep       Date:  2009-02-02

4.  Carbamazepine and multiple myeloma: possible interaction.

Authors:  Meral Günaldı; Semra Paydaş; Ciğdem Usul Afşar; Berna Bozkurt Duman; Vehbi Erçolak; Veysel Haksöyler
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

Review 5.  Fever of unknown origin due to zoonoses.

Authors:  Dennis J Cleri; Anthony J Ricketti; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2007-12       Impact factor: 5.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.